Cargando…

ELISPOT assays with pp65 peptides or whole HCMV antigen are reliable predictors of immune control of HCMV infection in seropositive kidney transplant recipients

Human cytomegalovirus (HCMV) infection represents a major complication for solid organ transplant recipients. The aim of this study was to verify if the measurement of HCMV‐specific T‐cells could help to identify patients protected against HCMV disease cytokine flow cytometry using infected dendriti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zavaglio, Federica, Rivela, Francesca, Cassaniti, Irene, Arena, Francesca, Gabanti, Elisa, Asti, Anna L., Lilleri, Daniele, Rampino, Teresa, Baldanti, Fausto, Gregorini, Marilena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108170/ https://www.ncbi.nlm.nih.gov/pubmed/36655741 http://dx.doi.org/10.1002/jmv.28507

Ejemplares similares

Human Cytomegalovirus (HCMV)-Specific CD4(+) and CD8(+) T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-Organ Transplant Recipients
por: Gabanti, Elisa, et al.
Publicado: (2014)

Characterization of Varicella-Zoster (VZV) Specific T Cell Response in Healthy Subjects and Transplanted Patients by Using Enzyme Linked Immunospot (ELISpot) Assays
por: Cassaniti, Irene, et al.
Publicado: (2021)

Sustained impairment of human cytomegalovirus (HCMV)-specific CD4(+ )and CD8(+ )T cell response is responsible for recurrent episodes of disseminated HCMV infection in a D(+)R(- )hand transplant recipient
por: Baldanti, Fausto, et al.
Publicado: (2008)

Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay
por: Cassaniti, Irene, et al.
Publicado: (2019)

Emergence of Letermovir-resistant HCMV UL56 mutant during rescue treatment in a liver transplant recipient with ganciclovir-resistant infection HCMV: a case report
por: Paolucci, Stefania, et al.
Publicado: (2021)

Alveolar Macrophages Isolated Directly From Human Cytomegalovirus (HCMV)–Seropositive Individuals Are Sites of HCMV Reactivation In Vivo
por: Poole, Emma, et al.
Publicado: (2015)

Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant
por: Cassaniti, Irene, et al.
Publicado: (2021)

Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients
por: Cassaniti, Irene, et al.
Publicado: (2022)

Differential outcome of neurological HCMV infection in two hematopoietic stem cell transplant recipients
por: Colombo, Anna Amelia, et al.
Publicado: (2012)

Large-Scale Screening of HCMV-Seropositive Blood Donors Indicates that HCMV Effectively Escapes from Antibodies by Cell-Associated Spread
por: Falk, Jessica Julia, et al.
Publicado: (2018)

Robust and Persistent B- and T-Cell Responses after COVID-19 in Immunocompetent and Solid Organ Transplant Recipient Patients
por: Zavaglio, Federica, et al.
Publicado: (2021)

HCMV Infection and Apoptosis: How Do Monocytes Survive HCMV Infection?
por: Collins-McMillen, Donna, et al.
Publicado: (2018)

Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
por: Shibamura, Miho, et al.
Publicado: (2020)

Performance of Whole Blood Stimulation Assays for the Quantification of SARS-CoV-2 Specific T-Cell Response: A Cross-Sectional Study
por: Bergami, Federica, et al.
Publicado: (2022)

Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patients
por: Cariani, Elisabetta, et al.
Publicado: (2007)

Suppressive effects of pterostilbene on human cytomegalovirus (HCMV) infection and HCMV-induced cellular senescence
por: Wang, Sanying, et al.
Publicado: (2022)

Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models
por: Lübke, Maren, et al.
Publicado: (2019)

Insight for Immunotherapy of HCMV Infection
por: Long, Xinmiao, et al.
Publicado: (2021)

Human Cytomegalovirus (HCMV)-infected Astrocytoma Cells Impair the Function of HCMV-specific Cytotoxic T Cells
por: Kim, Jiyeon, et al.
Publicado: (2020)

Tuning the Orchestra: HCMV vs. Innate Immunity
por: Dell’Oste, Valentina, et al.
Publicado: (2020)

B cell epitope of human cytomegalovirus phosphoprotein 65 (HCMV pp65) induced anti-dsDNA antibody in BALB/c mice
por: HoHsieh, Ao, et al.
Publicado: (2017)

Gene cloning of the human cytomegalovirus (HCMV) antigen reactive with the serum from a HCMV-infected patient.
por: Kim, M. N., et al.
Publicado: (1994)

Single Chain Antibodies Against gp55 of Human Cytomegalovirus (HCMV) for Prophylaxis and Treatment of HCMV Infections
por: Moazen, Bahareh, et al.
Publicado: (2016)

A Viral Pilot for HCMV Navigation?
por: Adler, Barbara
Publicado: (2015)

HCMV latency: what regulates the regulators?
por: Elder, Elizabeth, et al.
Publicado: (2019)

HCMV Envelope Glycoprotein Diversity Demystified
por: Foglierini, Mathilde, et al.
Publicado: (2019)

Challenging the Conventional Interpretation of HCMV Seronegativity
por: Waters, Shelley, et al.
Publicado: (2021)

Enhanced Induction of T Cell Immunity Using Dendritic Cells Pulsed with HIV Tat and HCMV-pp65 Fusion Protein In Vitro
por: Park, Jung-Sun, et al.
Publicado: (2011)

Variants of HCMV UL18 Sequenced Directly from Clinical Specimens Associate with Antibody and T-Cell Responses to HCMV
por: Waters, Shelley, et al.
Publicado: (2022)

"pp65 antigenemia and real time polymerase chain reaction (PCR) based-study to determine the prevalence of human cytomegalovirus (HCMV) in kidney donors and recipients with follow-up studies."
por: Madhavan, Hajib N, et al.
Publicado: (2010)

Discordance Between the Predicted Versus the Actually Recognized CD8+ T Cell Epitopes of HCMV pp65 Antigen and Aleatory Epitope Dominance
por: Lehmann, Alexander A., et al.
Publicado: (2021)

Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers
por: Bergami, Federica, et al.
Publicado: (2022)

The microRNA Transcriptome of Human Cytomegalovirus (HCMV)
por: Meshesha, Mesfin K, et al.
Publicado: (2012)

Increased HCMV seroprevalence in patients with hepatocellular carcinoma
por: Lepiller, Quentin, et al.
Publicado: (2011)

US28: HCMV’s Swiss Army Knife
por: Krishna, Benjamin A., et al.
Publicado: (2018)

Intragenic variations in the HCMV RL11-family
por: Sekulin, K., et al.
Publicado: (2006)

Small Molecules—Prospective Novel HCMV Inhibitors
por: Bogner, Elke, et al.
Publicado: (2021)

CARs—A New Perspective to HCMV Treatment
por: Bednar, Christopher, et al.
Publicado: (2021)

HCMV Antivirals and Strategies to Target the Latent Reservoir
por: Perera, Marianne R., et al.
Publicado: (2021)

CRM197-conjugated peptides vaccine of HCMV pp65 and gH induce maturation of DC and effective viral-specific T cell responses
por: Zhang, Shuyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r2fk10f48l4u7g9vratqu8ishu